WeVote
Log In

Bill

Bill

S 3669

Limits regulated perfluoroalkyl and polyfluoroalkyl substances in menstrual products.*

2024-2025 Regular Session Introduced by Joe Cryan and 5 co-sponsors

New Jersey bill would ban or limit PFAS "forever chemicals" in menstrual products to reduce direct tissue exposure to persistent synthetic compounds linked to health risks.

Referred to Senate Budget and Appropriations Committee
#consumerpro #health
0
WeVote Research Nonpartisan
Bill Summary · S 3669

Legislative bill overview

S 3669 would establish regulatory limits on "forever chemicals" (PFAS—perfluoroalkyl and polyfluoroalkyl substances) in menstrual products sold in New Jersey. These synthetic chemicals are used in some menstrual products for absorbency and fluid resistance but persist indefinitely in the environment and human tissue.

Why is this important

PFAS chemicals have been linked to health concerns including immune system effects, thyroid disease, and developmental issues. Menstrual products are in direct contact with sensitive tissues and are used repeatedly throughout a person's lifetime, raising particular health exposure concerns. This would be among the first state-level restrictions on PFAS in consumer menstrual products.

Potential points of contention

  • Manufacturing feasibility: Manufacturers may argue that reformulating products to eliminate PFAS while maintaining absorbency and leak protection is technically difficult or costly, potentially raising product prices or limiting availability
  • Scientific sufficiency: Debate over whether current evidence of harm from PFAS in menstrual products specifically justifies regulatory action versus addressing PFAS in other sources (drinking water, food packaging, non-stick cookware)
  • Enforcement and compliance timeline: Questions about how the state would test and enforce limits, and whether manufacturers would have adequate time to reformulate before implementation deadlines

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.